Roivant Sciences (ROIV) Change in Cash (2020 - 2026)

Roivant Sciences (ROIV) has 6 years of Change in Cash data on file, last reported at -$1.2 billion in Q4 2025.

• Quarterly Change in Cash rose 72.81% year-over-year to -$1.2 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$7.3 billion (down 78.17% YoY) and the FY2026 annual result came in at -$1.3 billion, up 66.15% from the prior year.
• Change in Cash declined to -$1.2 billion in Q4 2025, from -$1.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $5.0 billion in Q4 2023 to a low of -$4.5 billion in Q4 2024.
• A 5-year average of -$506.9 million and a median of -$242.5 million in 2023 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2023 — Change in Cash jumped 1036.84% — and 2024, when it tumbled 13748.95%.
• Tracing ROIV's Change in Cash over 5 years: stood at $84.5 million in 2021, then tumbled by 731.07% to -$533.0 million in 2022, then jumped by 1036.84% to $5.0 billion in 2023, then sank by 191.1% to -$4.5 billion in 2024, then jumped by 72.81% to -$1.2 billion in 2025.
• The last three Change in Cash figures came in at -$1.2 billion (Q4 2025), -$1.4 million (Q3 2025), and -$1.5 billion (Q2 2025), per Business Quant data.